Cargando…

Physicochemical Studies and Anticancer Potency of Ruthenium η(6)-p-Cymene Complexes Containing Antibacterial Quinolones

[Image: see text] With the aim of exploring the anticancer properties of organometallic compounds with bioactive ligands, Ru(arene) compounds of the antibacterial quinolones nalidixic acid (2) and cinoxacin (3) were synthesized, and their physicochemical properties were compared to those of chlorido...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kljun, Jakob, Bytzek, Anna K., Kandioller, Wolfgang, Bartel, Caroline, Jakupec, Michael A., Hartinger, Christian G., Keppler, Bernhard K., Turel, Iztok
Formato:	Texto
Lenguaje:	English
Publicado:	American Chemical Society 2011
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086571/ https://www.ncbi.nlm.nih.gov/pubmed/21552495 http://dx.doi.org/10.1021/om101180c

Ejemplares similares

Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group
por: Mokesch, Stephan, et al.
Publicado: (2019)

Dichlorido(η(6)-p-cymene)(ethoxydiphenylphosphane)ruthenium(II)
por: Knapp, Spring M. M., et al.
Publicado: (2012)

Dichlorido(η(6)-p-cymene)(4-fluoroaniline-κN)ruthenium(II)
por: Sykora, Richard E., et al.
Publicado: (2010)

Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
por: Kljun, Jakob, et al.
Publicado: (2023)

(η(6)-p-Cymene)bis(trichloridostannyl)(triethoxyphosphine-κP)ruthenium(II)
por: Shapovalov, Sergey S., et al.
Publicado: (2009)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Anticancer and antimicrobial properties of novel η(6)-p-cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization
por: Namiecińska, Ewelina, et al.
Publicado: (2019)

Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
por: Hanif, Muhammad, et al.
Publicado: (2013)

Dichlorido(η(6)-p-cymene)[tris(4-methoxyphenyl)phosphane]ruthenium(II)
por: Davis, Wade L., et al.
Publicado: (2021)

Ruthenium(II)(η(6)-arene) Complexes of Thiourea Derivatives: Synthesis, Characterization and Urease Inhibition
por: Hanif, Muhammad, et al.
Publicado: (2014)

Crystal structure of [3-amino-2-(phenyldiazenyl)pyridine]chlorido(η(6)-p-cymene)ruthenium(II) chloride
por: Hansongnern, Kanidtha, et al.
Publicado: (2015)

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents
por: Pujante-Galián, María Angeles, et al.
Publicado: (2020)

μ-Pyrazine-2,5-dicarboxylato-bis[chlorido(η(6)-p-cymene)ruthenium(II)] tert-butanol disolvate
por: Sanchez Ballester, Noelia M., et al.
Publicado: (2008)

Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines
por: Geisler, Heiko, et al.
Publicado: (2022)

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
por: Adhireksan, Zenita, et al.
Publicado: (2014)

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

Tetraethylammonium trichlorido(η(6)-p-cymene)ruthenate(II)
por: Wu, Fang-Hui, et al.
Publicado: (2009)

Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells
por: Mühlgassner, Gerhard, et al.
Publicado: (2012)

Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected β-Diketone, 8-Hydroxyquinoline and Pyrithione Ligands
por: Pivarcsik, Tamás, et al.
Publicado: (2021)

Biological Activity of Some Magnesium(II) Complexes of Quinolones
por: Turel, Iztok, et al.
Publicado: (2000)

Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC–ICP–MS
por: Klose, Matthias H. M., et al.
Publicado: (2018)

Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles
por: Novak, Maria S., et al.
Publicado: (2016)

(2,2′-Bipyridyl)(η(6)-p-cymene)iodidoruthenium(II) hexafluoridophosphate
por: Kelani, Monsuru T., et al.
Publicado: (2023)

Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates
por: Uršič, Matija, et al.
Publicado: (2017)

Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles
por: Mokesch, Stephan, et al.
Publicado: (2020)

(η(6)-p-Cymene)(1,3-dimesityl-2,3-dihydro-1H-imidazol-2-ylidene)bis(pentafluorobenzoato-κO)ruthenium(II) dichloromethane disolvate
por: Dorst, Konstantin, et al.
Publicado: (2012)

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
por: Seršen, Sara, et al.
Publicado: (2019)

[(1R)-3-Benzoyl-1,7,7-trimethylbicyclo[2.2.1]heptan-2-onato-κ(2) O,O′]chlorido(η(6)-p-cymene)ruthenium(II)
por: Harrad, Mohamed Anouar, et al.
Publicado: (2010)

Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017)

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects
por: Berasaluce, Iker, et al.
Publicado: (2019)

Facile Arene Ligand Exchange in p-Cymene Ruthenium(II) Complexes of Tertiary P-Chiral Ferrocenyl Phosphines
por: Popp, John, et al.
Publicado: (2019)

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer
por: Domínguez-Jurado, Elena, et al.
Publicado: (2021)

Synthesis, Characterization, and Cytotoxicity Studies of N-(4-Methoxybenzyl) Thiosemicarbazone Derivatives and Their Ruthenium(II)-p-cymene Complexes
por: Martínez-Estévez, Mónica, et al.
Publicado: (2022)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
por: Flocke, Lea S., et al.
Publicado: (2016)

Synthesis and in vitro Antitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand
por: Galanski, Markus, et al.
Publicado: (2005)

Quinolone Safety and Efficacy More Important than Potency
por: Frothingham, Richard
Publicado: (2004)

Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors
por: Legina, Maria S., et al.
Publicado: (2020)

NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells
por: Garufi, Alessia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_904r1pea1l7e3red72q7b5dkoi